Search Orphan Drug Designations and Approvals
-
| Generic Name: | an antibody-drug conjugate composed of the humanized monoclonal antibody against ROR1, conjugated to MMAE through a mc-vc-PAB cleavable linker |
|---|---|
| Date Designated: | 02/25/2025 |
| Orphan Designation: | treatment of mantle cell lymphoma |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd 866 Moganshan Road Hangzhou, Zhejiang 310011 China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







